Skip to main content
LIPID MAPS®
menu
Databases
LMSD
LMPD
COMP_DB
LMISSD
Ion Mobility
Partial Spectra DB
Standards Spectra DB
Oxidized Phospholipid DB
Shorthand DB
Pathways
Reactions Explorer
LIPID MAPS® Pathways
SphinGOMAP©
Cayman Pathway Maps
Tools
Lipidomics
Tool Guide
MS Analysis
Structure
Drawing
Statistical
Analysis
Nomenclature
Tools
Lipid Analysis
Software
Education
Webinars
Podcasts
Tutorials
Resources
Classification
Nomenclature
Structure
Methods and
Protocols
Training
School
Community
Lipid of the
Month
Lipid Matters
Blog
Highlights
LipidWeb
Newsletters
External
Resources
Events Calendar
About
About Us
About Our
Partners
About Our
Sponsors
Sponsor Us
Contact Us
Archive
Downloads
Downloads Hub (All)
Experimental Data
REST
SPARQL
LMSD
LMPD
COMP_DB
PARTIAL_DB
Standards Spectra DB
login
Login
Microarray analysis of bone marrow-derived macrophage cells treated with Kdo
2
-lipid A (KLA) and ATP
Search by fold change ratio
|
Search by KEGG pathway
|
Search by LIPID MAPS lipid pathway
Kdo
2
-Lipid A / ATP gene array data - treatment:control ratios
KEGG pathway: Riboflavin metabolism (mmu00740)
Legend:
: View data/graphs for replicates
Gene symbol  
Time course plot
Accession
Description
Treatment
15min
30min
1hr
2hr
4hr
8hr
20hr
AK134499
KLA
ATP
ATP+KLA
AK134499
11 days embryo head cDNA, RIKEN full-length enriched library, clone:6230419C23 product:unclassifiable, full insert sequence [AK134499]
KLA
.97
1.04
.99
1.01
.93
1.08
1.21
ATP
.97
1.02
.97
1.13
1.01
.98
1.06
KLA/ATP
.95
.98
1.00
.95
1.00
.98
1.02
Acp1
KLA
ATP
ATP+KLA
NM_001110239
acid phosphatase 1, soluble (Acp1), transcript variant 1, mRNA [NM_001110239]
KLA
1.15
1.18
1.12
1.18
1.14
1.10
1.18
ATP
.94
1.01
1.12
1.23
.90
.68
.98
KLA/ATP
1.10
1.24
1.20
1.33
.94
.82
.99
Acp2
KLA
ATP
ATP+KLA
AK170658
NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630113A07 product:acid phosphatase 2, lysosomal, full insert sequence [AK170658]
KLA
1.17
1.24
1.33
1.51
2.46
3.34
3.43
ATP
.95
.99
.76
1.07
.73
.56
.97
KLA/ATP
1.23
1.23
.78
1.06
.72
.78
2.19
Acp2
KLA
ATP
ATP+KLA
NM_007387
acid phosphatase 2, lysosomal (Acp2), mRNA [NM_007387]
KLA
1.52
1.61
1.73
1.82
2.82
4.19
5.68
ATP
1.12
1.21
.95
1.29
.87
.76
2.68
KLA/ATP
1.81
1.80
1.24
1.72
1.04
1.16
5.43
Acp5
KLA
ATP
ATP+KLA
NM_007388
acid phosphatase 5, tartrate resistant (Acp5), transcript variant 3, mRNA [NM_007388]
KLA
3.62
3.55
3.27
3.26
3.31
3.93
5.79
ATP
.96
1.00
1.29
1.96
2.30
3.05
3.81
KLA/ATP
3.61
3.85
4.05
5.38
4.56
5.15
6.77
Acp6
KLA
ATP
ATP+KLA
NM_019800
acid phosphatase 6, lysophosphatidic (Acp6), mRNA [NM_019800]
KLA
.56
.47
.41
.37
.24
.32
.79
ATP
.88
.80
1.06
.84
.62
.51
.67
KLA/ATP
.49
.44
.49
.36
.34
.37
.39
Acpp
KLA
ATP
ATP+KLA
NM_019807
acid phosphatase, prostate (Acpp), transcript variant 2, mRNA [NM_019807]
KLA
1.09
1.07
1.11
1.23
1.20
1.08
1.14
ATP
1.00
1.02
1.07
1.03
1.00
2.39
3.55
KLA/ATP
1.02
1.12
1.04
1.10
1.05
1.69
4.36
Acpp
KLA
ATP
ATP+KLA
NM_207668
acid phosphatase, prostate (Acpp), transcript variant 1, mRNA [NM_207668]
KLA
1.15
1.01
1.13
1.13
1.12
1.06
1.12
ATP
.96
1.02
1.04
1.02
.96
2.62
2.40
KLA/ATP
1.00
1.04
1.09
1.08
1.15
1.91
2.69
Blvrb
KLA
ATP
ATP+KLA
NM_144923
biliverdin reductase B (flavin reductase (NADPH)) (Blvrb), mRNA [NM_144923]
KLA
.92
.92
.90
.97
1.03
1.08
1.45
ATP
1.08
1.10
1.14
1.22
1.28
2.18
1.75
KLA/ATP
.97
.92
.94
1.10
1.24
1.96
2.58
Enpp1
KLA
ATP
ATP+KLA
ENSMUST00000105520
ens|Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E- NPP 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) (Lymphocyte antigen 41) (Ly-41) [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1
KLA
.71
.79
.64
.61
.55
.51
.32
ATP
.85
.97
.85
.72
.62
.45
.28
KLA/ATP
.72
.73
.61
.66
.60
.55
.27
Enpp1
KLA
ATP
ATP+KLA
NM_008813
ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1), mRNA [NM_008813]
KLA
.82
.83
.77
.83
.65
.64
.51
ATP
.89
.90
1.21
1.00
.98
.87
.64
KLA/ATP
.72
.76
.96
.87
1.00
.94
.51
Enpp3
KLA
ATP
ATP+KLA
BC005527
ectonucleotide pyrophosphatase [BC005527]
KLA
1.06
.99
.98
1.01
.97
.99
.96
ATP
.93
1.08
.99
1.05
.94
1.05
1.10
KLA/ATP
.95
.96
1.10
.99
.95
.94
1.03
Enpp3
KLA
ATP
ATP+KLA
BC006944
ectonucleotide pyrophosphatase/phosphodiesterase 3, mRNA (cDNA clone IMAGE:2655671), complete cds. [BC006944]
KLA
1.02
1.01
1.03
1.08
1.04
1.01
1.01
ATP
.97
1.01
.96
1.00
.98
1.07
.99
KLA/ATP
1.01
.99
1.07
1.02
.97
.98
.92
Enpp3
KLA
ATP
ATP+KLA
NM_134005
ectonucleotide pyrophosphatase/phosphodiesterase 3 (Enpp3), mRNA [NM_134005]
KLA
1.01
.95
.99
.98
1.05
1.04
.98
ATP
.98
.98
1.03
.98
.96
1.00
.98
KLA/ATP
.97
1.03
1.04
.93
1.02
.99
1.04
Flad1
KLA
ATP
ATP+KLA
NM_177041
RFad1, flavin adenine dinucleotide synthetase, homolog (yeast) (Flad1), mRNA [NM_177041]
KLA
.86
.91
.90
1.00
1.13
1.42
1.85
ATP
.94
.96
.95
.99
.68
1.02
2.24
KLA/ATP
.84
.82
.78
.87
.70
1.08
2.77
Mm.23812
7
KLA
ATP
ATP+KLA
168823498
Unknown
KLA
1.07
.97
1.04
1.05
1.02
.98
1.02
ATP
.95
1.00
.98
1.01
.95
.93
.92
KLA/ATP
.93
.98
.98
1.04
1.01
1.02
.98
Mm.35983
1
KLA
ATP
ATP+KLA
159032061
Unknown
KLA
1.02
.93
.95
.94
1.01
.97
1.11
ATP
.97
1.01
1.07
1.03
.93
1.03
1.02
KLA/ATP
.94
.91
.99
.97
.97
.98
.91
Rfk
KLA
ATP
ATP+KLA
NM_019437
riboflavin kinase (Rfk), mRNA [NM_019437]
KLA
1.03
1.05
.97
.96
.86
.77
.86
ATP
1.05
1.20
1.16
1.43
1.21
1.23
1.24
KLA/ATP
1.04
1.09
.95
1.20
.91
.93
1.03
Tyr
KLA
ATP
ATP+KLA
NM_011661
tyrosinase (Tyr), mRNA [NM_011661]
KLA
.99
1.02
.99
1.01
1.00
1.01
1.03
ATP
1.01
.98
.99
1.03
1.00
1.01
1.00
KLA/ATP
1.01
1.00
1.00
1.01
1.00
1.03
.98